These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 29212198)

  • 1. Targeting oral cancer stemness and chemoresistance by isoliquiritigenin-mediated GRP78 regulation.
    Hu FW; Yu CC; Hsieh PL; Liao YW; Lu MY; Chu PM
    Oncotarget; 2017 Nov; 8(55):93912-93923. PubMed ID: 29212198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Berberine-targeted miR-21 chemosensitizes oral carcinomas stem cells.
    Lin CY; Hsieh PL; Liao YW; Peng CY; Lu MY; Yang CH; Yu CC; Liu CM
    Oncotarget; 2017 Oct; 8(46):80900-80908. PubMed ID: 29113353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GMI ablates cancer stemness and cisplatin resistance in oral carcinomas stem cells through IL-6/Stat3 signaling inhibition.
    Wang TY; Yu CC; Hsieh PL; Liao YW; Yu CH; Chou MY
    Oncotarget; 2017 Sep; 8(41):70422-70430. PubMed ID: 29050290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling.
    Wang N; Wang Z; Peng C; You J; Shen J; Han S; Chen J
    Carcinogenesis; 2014 Nov; 35(11):2544-54. PubMed ID: 25194164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnolol inhibits cancer stemness and IL-6/Stat3 signaling in oral carcinomas.
    Peng CY; Yu CC; Huang CC; Liao YW; Hsieh PL; Chu PM; Yu CH; Lin SS
    J Formos Med Assoc; 2022 Jan; 121(1 Pt 1):51-57. PubMed ID: 33551310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
    Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
    J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox2 expression involvement in the oncogenicity and radiochemoresistance of oral cancer stem cells.
    Chou MY; Hu FW; Yu CH; Yu CC
    Oral Oncol; 2015 Jan; 51(1):31-9. PubMed ID: 25456004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitizing effect of honokiol in oral carcinoma stem cells via regulation of IL-6/Stat3 signaling.
    Chang MT; Lee SP; Fang CY; Hsieh PL; Liao YW; Lu MY; Tsai LL; Yu CC; Liu CM
    Environ Toxicol; 2018 Nov; 33(11):1105-1112. PubMed ID: 30076764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC00963 Promotes Cancer Stemness, Metastasis, and Drug Resistance in Head and Neck Carcinomas via ABCB5 Regulation.
    Lee SP; Hsieh PL; Fang CY; Chu PM; Liao YW; Yu CH; Yu CC; Tsai LL
    Cancers (Basel); 2020 Apr; 12(5):. PubMed ID: 32357409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1246 Targets CCNG2 to Enhance Cancer Stemness and Chemoresistance in Oral Carcinomas.
    Lin SS; Peng CY; Liao YW; Chou MY; Hsieh PL; Yu CC
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30115848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFATc3 plays an oncogenic role in oral/oropharyngeal squamous cell carcinomas by promoting cancer stemness via expression of OCT4.
    Lee SH; Kieu C; Martin CE; Han J; Chen W; Kim JS; Kang MK; Kim RH; Park NH; Kim Y; Shin KH
    Oncotarget; 2019 Mar; 10(23):2306-2319. PubMed ID: 31040921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoliquiritigenin Inhibits Gastric Cancer Stemness, Modulates Tumor Microenvironment, and Suppresses Tumor Growth through Glucose-Regulated Protein 78 Downregulation.
    Lee CH; Tsai HY; Chen CL; Chen JL; Lu CC; Fang YP; Wu DC; Huang YB; Lin MW
    Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation.
    Lee SH; Lee CR; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
    Papillomavirus Res; 2015 Dec; 1():116-125. PubMed ID: 26693182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL.
    Yu CC; Chang YC
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):459-69. PubMed ID: 23219715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovatodiolide Suppresses Oral Cancer Malignancy by Down-Regulating Exosomal Mir-21/STAT3/β-Catenin Cargo and Preventing Oncogenic Transformation of Normal Gingival Fibroblasts.
    Chen JH; Wu ATH; Bamodu OA; Yadav VK; Chao TY; Tzeng YM; Mukhopadhyay D; Hsiao M; Lee JC
    Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31878245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
    Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
    Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-146a participates in the regulation of cancer stemness of oral carcinoma cells.
    Liu YT; Yu CC; Lu MY; Chao SC; Liao YW; Yu CH; Lee YH
    J Dent Sci; 2023 Apr; 18(2):503-509. PubMed ID: 37021226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 in stage I and II oral squamous cell carcinoma and their association with clinicopathological factors.
    Tamatani T; Takamaru N; Ohe G; Akita K; Nakagawa T; Miyamoto Y
    Oncol Lett; 2018 Jul; 16(1):1133-1140. PubMed ID: 29963189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Stem Cells in Oral Squamous Cell Carcinoma: A Narrative Review on Experimental Characteristics and Methodological Challenges.
    Acharya SK; Shai S; Choon YF; Gunardi I; Hartanto FK; Kadir K; Roychoudhury A; Amtha R; Vincent-Chong VK
    Biomedicines; 2024 Sep; 12(9):. PubMed ID: 39335624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.